APPROACH UNDER REVIEW: `prompt-only`

SCENARIO ID: scenario_20
APP DESCRIPTION: BabyCheck delivers the Edinburgh Postnatal Depression Scale (EPDS) weekly post-birth and flags scores ≥10 with a recommendation to contact the midwife or GP. Integrated with maternity-clinic platforms. EU + CH.

DEVELOPER PERSONA: Co-founder, midwife by background.

EXPECTED HERA DIMENSIONS (gold standard): P1.D1, P1.D2, P1.D4, P2.D1, P2.D6, P3.D1, P3.D2, P5.D2, P5.D3, P7.D1, P7.D2

TRANSCRIPT:
### USER
BabyCheck delivers the Edinburgh Postnatal Depression Scale (EPDS) weekly post-birth and flags scores ≥10 with a recommendation to contact the midwife or GP. Integrated with maternity-clinic platforms. EU + CH.

### ASSISTANT
Let's begin by identifying potential **ethical and regulatory risks** in **BabyCheck** using the **HERA taxonomy**. We'll focus on the **7 pillars** and **38 dimensions**, and explore the implications of the app's design and functionality.

---

### 🧠 **P1. Data Privacy & Security**  
**[P1.D1] Data Collection & Processing**  
**Reflection Question:**  
*What data is being collected by BabyCheck, and how is it being processed?*  

**Risk Consideration:**  
- The app collects **health data** (EPDS scores) and **user identifiers** (if integrated with maternity platforms).
- **GDPR** requires that data collection be **lawful, fair, and transparent**.
- **MDR** (Medical Device Regulation) applies if the app is considered a **medical device**, requiring **data security** and **data minimization**.

**Mitigation Suggestion:**  
- Ensure **explicit consent** is obtained for data collection and processing.
- Implement **data minimization** by collecting only the necessary data (e.g., EPDS scores, user ID).
- Use **encryption** and **secure storage** for all health data in compliance with **GDPR Article 30** and **MDR Annex I**.

---

### 🧠 **P2. Risk Management & Safety**  
**[P2.D3] Risk Mitigation & Safety Monitoring**  
**Reflection Question:**  
*How does BabyCheck ensure the safety of users and the accuracy of the EPDS scoring?*  

**Risk Consideration:**  
- The EPDS is a **screening tool**, not a **diagnostic tool**. Misinterpretation of scores could lead to **false reassurance** or **unnecessary referrals**.
- **EU AI Act** requires **risk assessment** for AI systems that pose **high risk** (e.g., those used in health).
- **ISO 82304-2** (Software for Medical Purposes) applies if the app is a **software medical device**.

**Mitigation Suggestion:**  
- Clearly label the EPDS as a **screening tool**, not a **diagnostic tool**.
- Include **disclaimer statements** in the app to avoid **misinterpretation**.
- Conduct **risk assessments** in line with **ISO 82304-2** and **EU AI Act**.

---

### 🧠 **P3. Transparency & Accountability**  
**[P3.D2] Transparency of Decision-Making**  
**Reflection Question:**  
*Is the algorithm used to flag scores ≥10 transparent to users and healthcare professionals?*  

**Risk Consideration:**  
- If the app uses an **AI algorithm** to flag scores, it must be **transparent** under the **EU AI Act**.
- **GDPR** requires **right to explanation** for automated decisions that have **legal or significant effects**.
- **MDR** requires **traceability** and **documentation** of the device's performance.

**Mitigation Suggestion:**  
- Provide **explanations** of how the scoring is calculated and why a score ≥10 is flagged.
- Document the **algorithmic logic** and **decision-making process** for **auditability**.
- Ensure **human oversight** is in place for **high-risk decisions**.

---

### 🧠 **P4. Human Oversight & Control**  
**[P4.D1] Human Oversight in Decision-Making**  
**Reflection Question:**  
*Is there a mechanism for human oversight in the flagging process?*  

**Risk Consideration:**  
- The app **flags** scores ≥10, but the **final decision** to contact a midwife or GP must be made by a **human**.
- **EU AI Act** requires **human oversight** for high-risk AI systems.
- **MDR** requires that **human intervention** is possible and necessary for **safety-critical decisions**.

**Mitigation Suggestion:**  
- Ensure the app does **not replace** clinical judgment but **supports** it.
- Provide **clear guidance** to users and healthcare professionals on the **next steps** after a flag is raised.
- Implement **logging and audit trails** for all flagged cases to support **accountability**.

---

### 🧠 **P5. User Autonomy & Informed Consent**  
**[P5.D1] Informed Consent & User Control**  
**Reflection Question:**  
*Is the user fully informed about how their data is used, and do they have control over their data?*  

**Risk Consideration:**  
- Users must be **informed** about the purpose of the app, how their data is used, and their **right to withdraw consent**.
- **GDPR** requires **explicit consent** for data processing, especially for health data.
- **MDR** requires **user-friendly interfaces** and **clear

### USER
EPDS validated in PPD; we use the published cutoff (10).

### ASSISTANT
Great! You've clarified that the **EPDS** is being used with the **validated cutoff of ≥10** for **postpartum depression screening**, and it's being used in the **perinatal period (PPD)**. This adds **clinical validity** and **reduces some risk** around the **accuracy of the screening tool**. Let’s continue exploring **ethical and regulatory risks** using the **HERA taxonomy**, focusing on the **remaining pillars** and refining our earlier reflections.

---

### 🧠 **P3. Transparency & Accountability**  
**[P3.D3] Right to Explanation for Automated Decisions**  
**Reflection Question:**  
*Is the user or healthcare professional able to understand why a score ≥10 is flagged, and how the EPDS is scored?*  

**Risk Consideration:**  
- The EPDS is a **well-validated tool**, but **users may not understand** how the scoring works or why a score ≥10 is considered **clinically significant**.
- **GDPR** (Article 13–15) requires **clear information** about the **purpose and nature** of data processing.
- **EU AI Act** requires **transparency** for AI systems that make **high-risk decisions** (e.g., triggering a referral).

**Mitigation Suggestion:**  
- Include a **simple explanation** of the EPDS scoring system and the **clinical significance** of a score ≥10.
- Provide **visual aids** or **tooltips** in the app to help users understand the **meaning of their score**.
- Ensure that **healthcare professionals** are trained on the **clinical interpretation** of the EPDS.

---

### 🧠 **P4. Human Oversight & Control**  
**[P4.D2] Human Intervention in Safety-Critical Decisions**  
**Reflection Question:**  
*Is there a clear process for human intervention when a score ≥10 is flagged, and is it enforced?*  

**Risk Consideration:**  
- While the app **flags** scores ≥10, the **final decision to contact a midwife or GP** must be made by a **human**.
- **MDR** requires that **human intervention** is possible and **necessary** for **safety-critical decisions**.
- **EU AI Act** mandates **human oversight** for **high-risk AI systems** (e.g., those that influence healthcare decisions).

**Mitigation Suggestion:**  
- Ensure that the **flagging mechanism** is **non-binding** and that the **final action** is **left to the healthcare professional**.
- Log all **flagged cases** and **actions taken** to support **accountability** and **audit trails**.
- Provide **guidance** to healthcare professionals on how to **respond to flagged cases**.

---

### 🧠 **P5. User Autonomy & Informed Consent**  
**[P5.D2] Right to Withdraw Consent**  
**Reflection Question:**  
*Is the user able to easily withdraw their consent for data processing and the use of the EPDS tool?*  

**Risk Consideration:**  
- **GDPR** (Article 7) requires that **users can withdraw consent at any time**, and the **data must be deleted or anonymized**.
- **MDR** requires that users are **informed** about the **purpose and scope** of data processing.
- **EU AI Act** mandates **transparency** and **user control** over AI-driven decisions.

**Mitigation Suggestion:**  
- Include a **clear and accessible option** for users to **opt out** of data collection or the EPDS screening.
- Provide **instructions** on how to **delete their data** or **deactivate their account**.
- Ensure that **consent is not a prerequisite** for accessing the app, unless required by **regulatory compliance**.

---

### 🧠 **P6. Fairness & Non-Discrimination**  
**[P6.D1] Bias in Data and Algorithms**  
**Reflection Question:**  
*Is the EPDS tool used in a way that could inadvertently lead to bias or discrimination based on demographics?*  

**Risk Consideration:**  
- The EPDS is **validated** for **PPD**, but **cultural or linguistic differences** could affect its **accuracy** in diverse populations.
- **EU AI Act** requires **fairness** and **non-discrimination** in AI systems.
- **MDR** requires that **medical devices** do not **discriminate** against users based on **demographics**.

**Mitigation Suggestion:**  
- Ensure the app is **tested** across **diverse populations** and **languages**.
- Provide **multilingual support** and **cultural adaptations** where necessary.
- Monitor for **bias** in the use of the EPDS and **adjust** the tool if disparities are found.

---

### 

### USER
User can pause assessments; account delete wipes everything.

### ASSISTANT
Excellent! You've provided important **user control mechanisms** that help mitigate **privacy risks** and **data retention concerns**. Let’s continue analyzing these features through the **HERA taxonomy**, focusing on the **remaining pillars** and refining our risk assessment.

---

### 🧠 **P1. Data Privacy & Security**  
**[P1.D2] Data Retention & Deletion**  
**Reflection Question:**  
*Does the app ensure that data is deleted or anonymized when the user deletes their account?*  

**Risk Consideration:**  
- **GDPR Article 17** requires **right to be forgotten**, and data must be **deleted or anonymized** upon request.
- **MDR** requires **data minimization** and **secure deletion** of health data.
- **EU AI Act** mandates **data minimization** and **secure data handling** for AI systems.

**Mitigation Suggestion:**  
- Ensure that **deletion of the account** results in **complete removal of all user data** (including EPDS scores, user identifiers, and any linked health data).
- Implement **secure deletion** mechanisms (e.g., overwriting data, anonymization) to prevent **reconstruction** of user data.
- Provide **confirmation** to the user that their data has been **deleted** or **anonymized**.

---

### 🧠 **P5. User Autonomy & Informed Consent**  
**[P5.D3] Right to Control Data Usage**  
**Reflection Question:**  
*Does the app give users control over how their data is used, including the ability to pause assessments and delete data?*  

**Risk Consideration:**  
- **GDPR** (Article 6) requires **lawful basis** for data processing, and users must be **informed** of how their data is used.
- **MDR** requires **user-friendly interfaces** and **clear information** about data usage.
- **EU AI Act** mandates **user control** over AI-driven decisions.

**Mitigation Suggestion:**  
- Clearly communicate the **purpose and scope** of data collection in the **privacy policy** and **terms of service**.
- Ensure that **pausing assessments** and **deleting data** are **easy-to-find options** in the user interface.
- Provide **real-time feedback** when users pause or delete their data (e.g., confirmation messages).

---

### 🧠 **P6. Fairness & Non-Discrimination**  
**[P6.D2] Accessibility & Inclusivity**  
**Reflection Question:**  
*Is the app accessible to users with disabilities, and is the EPDS tool adapted for diverse populations?*  

**Risk Consideration:**  
- **EU AI Act** requires **non-discrimination** and **accessibility** for AI systems.
- **MDR** requires **inclusive design** and **accessibility** for medical devices.
- **GDPR** (Article 29) requires **reasonable accommodations** for users with disabilities.

**Mitigation Suggestion:**  
- Ensure the app is **WCAG-compliant** for **accessibility** (e.g., screen reader support, keyboard navigation).
- Provide **language options** and **cultural adaptations** to ensure **equitable access**.
- Test the EPDS tool for **cultural and linguistic bias** to ensure it is **equally effective** across diverse populations.

---

### 🧠 **P7. Societal Impact & Harm Prevention**  
**[P7.D1] Avoiding Harm to Users**  
**Reflection Question:**  
*Does the app have safeguards to prevent harm, such as false positives or false negatives in depression screening?*  

**Risk Consideration:**  
- **False positives** (scores ≥10 that are not clinically significant) could lead to **unnecessary referrals** and **stigma**.
- **False negatives** (scores <10 that are actually indicative of depression) could lead to **missed opportunities** for intervention.
- **EU AI Act** and **MDR** require **safety** and **risk prevention** in medical applications.

**Mitigation Suggestion:**  
- Include **disclaimer statements** that the EPDS is a **screening tool**, not a **diagnostic tool**.
- Provide **guidance** to users and healthcare professionals on how to **interpret scores** and **seek professional help**.
- Monitor for **clinical outcomes** and **user feedback** to refine the tool over time.

---

### ✅ Summary of Mitigations

| HERA Dimension | Risk | Mitigation |
|----------------|------|------------|
| **P1.D2** | Data retention and deletion | Ensure complete deletion of user data upon account deletion |
| **P5.D3** | User control over data | Provide clear options to pause assessments and delete data |
| **P6.D2** | Accessibility and inclusivity | Ensure WCAG compliance and cultural/linguistic

### USER
WCAG; DE/FR/IT/EN; low-literacy mode.

### ASSISTANT
Excellent! You’ve added **key accessibility and inclusivity features** that help mitigate **ethical and regulatory risks** related to **user access, language, and literacy**. Let’s continue exploring these through the **HERA taxonomy**, focusing on **P6 (Fairness & Non-Discrimination)** and **P7 (Societal Impact & Harm Prevention)**, and refining our risk assessment.

---

### 🧠 **P6. Fairness & Non-Discrimination**  
**[P6.D2] Accessibility & Inclusivity**  
**Reflection Question:**  
*Does the app ensure equitable access for users with disabilities, including support for low-literacy users and multiple languages?*  

**Risk Consideration:**  
- **EU AI Act** (Article 11) requires **non-discrimination** and **accessibility** for AI systems.
- **MDR** (Article 10) requires **inclusive design** and **accessibility** for medical devices.
- **GDPR** (Article 29) mandates **reasonable accommodations** for users with disabilities.
- **EU Accessibility Act** (2019/1620) requires **digital accessibility** for public sector services, which may apply to BabyCheck if it’s used by public maternity clinics.

**Mitigation Suggestion:**  
- Ensure the app is **WCAG 2.1 AA compliant** to meet **international accessibility standards**.
- Provide **language options** in **DE, FR, IT, and EN**, and ensure **translation quality** to avoid **misinterpretation**.
- Offer a **low-literacy mode** with **simple language**, **visual cues**, and **minimal text** to support **users with low literacy or cognitive challenges**.
- Conduct **user testing** with **diverse groups**, including **people with disabilities**, to ensure **equitable access** and **usability**.

---

### 🧠 **P7. Societal Impact & Harm Prevention**  
**[P7.D2] Avoiding Harm to Vulnerable Groups**  
**Reflection Question:**  
*Does the app have safeguards to prevent harm to vulnerable users, such as those with low literacy or limited language proficiency?*  

**Risk Consideration:**  
- **Low-literacy users** may misinterpret EPDS scores or not understand the **clinical significance** of a score ≥10.
- **Language barriers** could lead to **miscommunication** or **misuse** of the app.
- **EU AI Act** (Article 12) requires **risk assessments** for AI systems that could **harm users**.
- **MDR** (Article 10) requires **safety** and **risk prevention** in medical devices.

**Mitigation Suggestion:**  
- Use **clear, simple language** in all user interfaces and **avoid jargon**.
- Provide **visual indicators** (e.g., icons, color-coding) to help users understand their EPDS score.
- Include **supporting text or tooltips** to explain the **clinical meaning** of a score ≥10.
- Ensure that **language translations** are **accurate and culturally appropriate** to avoid **misinterpretation**.
- Provide **support channels** (e.g., helplines, in-app support) for users who need assistance interpreting their results.

---

### 🧠 **P6. Fairness & Non-Discrimination**  
**[P6.D3] Avoiding Discrimination in Data Use**  
**Reflection Question:**  
*Is the app designed to avoid discrimination based on language, literacy, or disability?*  

**Risk Consideration:**  
- **EU AI Act** (Article 11) requires **non-discrimination** in AI systems.
- **GDPR** (Article 29) mandates **reasonable accommodations** for users with disabilities.
- **MDR** (Article 10) requires **inclusive design** and **non-discrimination** in medical devices.

**Mitigation Suggestion:**  
- Ensure that the app’s **user interface and content** are **equally accessible** to all users, regardless of **language, literacy, or disability**.
- Test the app with **diverse user groups**, including those with **disabilities**, **low-literacy users**, and **non-native speakers**, to identify and address **barriers to access**.
- Provide **multilingual support** and **low-literacy mode** as **default options** where appropriate, to ensure **equitable access**.

---

### ✅ Summary of Mitigations

| HERA Dimension | Risk | Mitigation |
|----------------|------|------------|
| **P6.D2** | Accessibility & inclusivity | Ensure WCAG compliance, multilingual support, and low-literacy mode |
| **P7.D2** | Avoiding harm to vulnerable users | Use clear language, visual indicators, and support channels |
| **P6.D3** | Avoiding discrimination in

### USER
WCAG; DE/FR/IT/EN; low-literacy mode.

### ASSISTANT
You’ve provided **key accessibility and inclusivity features** that directly address **ethical and regulatory risks** in **P6 (Fairness & Non-Discrimination)** and **P7 (Societal Impact & Harm Prevention)**. Let’s finalize this by mapping these features to the **HERA taxonomy** and identifying **actionable mitigations** that align with **GDPR, MDR, EU AI Act, and accessibility standards**.

---

### 🧠 **P6. Fairness & Non-Discrimination**  
**[P6.D2] Accessibility & Inclusivity**  
**Reflection Question:**  
*Does the app ensure equitable access for users with disabilities, including support for low-literacy users and multiple languages?*  

**Risk Consideration:**  
- **EU AI Act (Article 11)**: Requires AI systems to be **non-discriminatory** and **accessible**.
- **MDR (Article 10)**: Requires **inclusive design** and **non-discrimination** in medical devices.
- **GDPR (Article 29)**: Mandates **reasonable accommodations** for users with disabilities.
- **EU Accessibility Act (2019/1620)**: Requires **digital accessibility** for public sector services, which may apply if the app is used by public maternity clinics.

**Mitigation Suggestion:**  
- Ensure the app is **WCAG 2.1 AA compliant** to meet **international accessibility standards**.
- Provide **language options** in **DE, FR, IT, and EN**, and ensure **translation quality** to avoid **misinterpretation**.
- Offer a **low-literacy mode** with **simple language**, **visual cues**, and **minimal text** to support **users with low literacy or cognitive challenges**.
- Conduct **user testing** with **diverse groups**, including **people with disabilities**, to ensure **equitable access** and **usability**.

---

### 🧠 **P7. Societal Impact & Harm Prevention**  
**[P7.D2] Avoiding Harm to Vulnerable Groups**  
**Reflection Question:**  
*Does the app have safeguards to prevent harm to vulnerable users, such as those with low literacy or limited language proficiency?*  

**Risk Consideration:**  
- **Low-literacy users** may misinterpret EPDS scores or not understand the **clinical significance** of a score ≥10.
- **Language barriers** could lead to **miscommunication** or **misuse** of the app.
- **EU AI Act (Article 12)**: Requires **risk assessments** for AI systems that could **harm users**.
- **MDR (Article 10)**: Requires **safety** and **risk prevention** in medical devices.

**Mitigation Suggestion:**  
- Use **clear, simple language** in all user interfaces and **avoid jargon**.
- Provide **visual indicators** (e.g., icons, color-coding) to help users understand their EPDS score.
- Include **supporting text or tooltips** to explain the **clinical meaning** of a score ≥10.
- Ensure that **language translations** are **accurate and culturally appropriate** to avoid **misinterpretation**.
- Provide **support channels** (e.g., helplines, in-app support) for users who need assistance interpreting their results.

---

### 🧠 **P6. Fairness & Non-Discrimination**  
**[P6.D3] Avoiding Discrimination in Data Use**  
**Reflection Question:**  
*Is the app designed to avoid discrimination based on language, literacy, or disability?*  

**Risk Consideration:**  
- **EU AI Act (Article 11)**: Requires AI systems to be **non-discriminatory**.
- **GDPR (Article 29)**: Mandates **reasonable accommodations** for users with disabilities.
- **MDR (Article 10)**: Requires **inclusive design** and **non-discrimination** in medical devices.

**Mitigation Suggestion:**  
- Ensure that the app’s **user interface and content** are **equally accessible** to all users, regardless of **language, literacy, or disability**.
- Test the app with **diverse user groups**, including those with **disabilities**, **low-literacy users**, and **non-native speakers**, to identify and address **barriers to access**.
- Provide **multilingual support** and **low-literacy mode** as **default options** where appropriate, to ensure **equitable access**.

---

### ✅ Final Summary of Mitigations

| HERA Dimension | Risk | Mitigation |
|----------------|------|------------|
| **P6.D2** | Accessibility & inclusivity | Ensure WCAG 2.1 AA compliance, multilingual support (DE, FR, IT, EN), and low-literacy mode |
| **P7.D2** | Avoid

### USER
WCAG; DE/FR/IT/EN; low-literacy mode.

### ASSISTANT
You've made excellent progress in addressing **accessibility, inclusivity, and user control**—key components of **P6 (Fairness & Non-Discrimination)** and **P7 (Societal Impact & Harm Prevention)**. Let’s now finalize the **HERA Risk & Safety Assessment** for your mHealth app, mapping your current features to the **HERA taxonomy**, and aligning them with **regulatory requirements** such as **GDPR, MDR, EU AI Act, and accessibility standards**.

---

### ✅ **HERA Risk & Safety Assessment Summary**

| **HERA Dimension** | **Risk** | **Mitigation** | **Regulation Alignment** |
|--------------------|----------|----------------|---------------------------|
| **P1.D2** | Data retention and deletion | Ensure complete deletion of user data upon account deletion | GDPR Article 17, MDR Article 10, EU AI Act |
| **P5.D3** | User control over data | Provide clear options to pause assessments and delete data | GDPR Article 6, MDR Article 10, EU AI Act |
| **P6.D2** | Accessibility & inclusivity | Ensure WCAG 2.1 AA compliance, multilingual support (DE, FR, IT, EN), and low-literacy mode | EU AI Act Article 11, MDR Article 10, GDPR Article 29, EU Accessibility Act |
| **P6.D3** | Avoiding discrimination in data use | Ensure equitable access for all users, including those with disabilities and low-literacy users | EU AI Act Article 11, MDR Article 10, GDPR Article 29 |
| **P7.D2** | Avoiding harm to vulnerable users | Use clear language, visual indicators, and support channels | EU AI Act Article 12, MDR Article 10, GDPR Article 29 |

---

### 📌 **Actionable Next Steps**

1. **WCAG Compliance**  
   - Conduct a **WCAG 2.1 AA audit** to ensure the app is accessible to users with disabilities.
   - Include **screen reader support**, **keyboard navigation**, and **color contrast** compliance.

2. **Language Support**  
   - Ensure **translation quality** for DE, FR, IT, and EN, and test for **cultural appropriateness**.
   - Avoid **literal translations** that may misinterpret the meaning of EPDS scores.

3. **Low-Literacy Mode**  
   - Implement a **simplified UI** with **icons, color-coding, and minimal text**.
   - Test with **low-literacy users** to ensure **clarity and usability**.

4. **User Testing**  
   - Conduct **user testing** with **diverse groups**, including users with **disabilities**, **non-native speakers**, and **low-literacy users**.
   - Gather **feedback** to refine the app’s **accessibility and usability**.

5. **Documentation & Transparency**  
   - Clearly document **data retention, deletion, and user control options** in the **privacy policy** and **terms of service**.
   - Include **disclaimer statements** that the EPDS is a **screening tool**, not a **diagnostic tool**.

---

### 🧾 **Regulatory Checklist**

| **Regulation** | **Key Requirements** |
|----------------|----------------------|
| **GDPR** | Right to be forgotten (Article 17), lawful basis for data processing (Article 6), accessibility (Article 29) |
| **MDR** | Data minimization, secure deletion (Article 10), inclusive design (Article 10) |
| **EU AI Act** | Non-discrimination (Article 11), accessibility (Article 11), risk assessment (Article 12) |
| **EU Accessibility Act** | Digital accessibility for public sector services (2019/1620) |

---

### 🎯 **Final Verdict**

✅ **Your app has strong foundations** in **user control, data privacy, and accessibility**.  
✅ With **WCAG compliance, multilingual support, and low-literacy mode**, you’re addressing key **ethical and regulatory requirements**.  
✅ **User testing and documentation** will help ensure **compliance** and **user trust**.

Would you like to proceed with a **risk assessment matrix** or **compliance checklist** for your development team?

### USER
WCAG; DE/FR/IT/EN; low-literacy mode.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Report for mHealth App (WCAG; DE/FR/IT/EN; low-literacy mode)**

---

### 🔍 **Risk Summary by Severity**

| **Severity** | **HERA Dimension** | **Risk Description** | **Mitigation** |
|--------------|--------------------|----------------------|----------------|
| **High**     | [P1.D2] Data Retention & Deletion | Users may not be fully informed about data retention and deletion processes. | Ensure clear user controls for data deletion and retention, aligned with GDPR Article 17 and MDR Article 10. |
| **High**     | [P5.D3] User Control Over Data | Users may not have sufficient control over their data, especially during active assessments. | Provide clear options to pause, stop, or delete data, as per GDPR Article 6 and MDR Article 10. |
| **Medium**   | [P6.D2] Accessibility & Inclusivity | Lack of full WCAG compliance may exclude users with disabilities or low-literacy users. | Implement WCAG 2.1 AA compliance, multilingual support (DE, FR, IT, EN), and low-literacy mode. |
| **Medium**   | [P7.D2] Avoiding Harm to Vulnerable Groups | Misinterpretation of EPDS scores by low-literacy or non-native speakers may lead to incorrect health decisions. | Use clear language, visual indicators, and support channels to explain EPDS scores. |
| **Medium**   | [P6.D3] Avoiding Discrimination in Data Use | Potential for discrimination based on language or literacy level if translations or low-literacy mode are not fully implemented. | Ensure equitable access for all users, including those with disabilities and low-literacy users. |

---

### ✅ **Mitigation Summary**

- **WCAG 2.1 AA Compliance**: Ensure the app is accessible to users with disabilities.
- **Multilingual Support**: Provide DE, FR, IT, and EN with accurate, culturally appropriate translations.
- **Low-Literacy Mode**: Simplify language, use icons, and minimize text for clarity.
- **User Control**: Allow users to pause, stop, and delete their data.
- **Transparency**: Clearly document data retention, deletion, and user rights in the privacy policy.

---

### 📋 **Dimensions Not Covered in This Report**

The following HERA dimensions were not addressed in this risk assessment due to scope or data limitations:

- [P1.D1] Data Collection & Purpose
- [P2.D1] Transparency & Explainability
- [P3.D1] Data Security & Integrity
- [P4.D1] Human Oversight & Accountability
- [P5.D1] User Autonomy & Consent
- [P5.D2] Data Minimization & Purpose Limitation
- [P7.D1] Societal Impact & Public Trust

---

### 📌 **Next Steps**

- Conduct a **full WCAG audit** and **user testing** with diverse groups.
- Finalize **privacy policy** and **terms of service** with clear data control options.
- Implement **language and low-literacy mode** with **user feedback loops**.
- Document **risk assessments** and **mitigation strategies** for regulatory compliance.

Let me know if you'd like a **risk matrix** or **regulatory checklist** for your development team.

Now produce the JSON judgement object.